The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?

As the Bundibugyo strain of Ebola spreads in the Democratic Republic of the Congo and Uganda, the urgent need for a vaccine or treatment has led to $60 million in emergency funding for three vaccine developers. The situation is complicated by security challenges in the conflict-ridden region, making it difficult to contain the outbreak. This funding aims to accelerate the development of a vaccine, but the timeline for its availability remains uncertain, highlighting the global urgency and stakes involved in combating this deadly virus.